| Autor: |
Sivakrishna, Balija, Islam, Sehbanul, Santra, Manas K., Pal, Shantanu |
| Předmět: |
|
| Zdroj: |
Drug Development Research; May2020, Vol. 81 Issue 3, p274-282, 9p |
| Abstrakt: |
In view of the potent anticancer activity of the d‐arabino‐configured cytosine nucleoside (ara‐C), apioarabinofuranosyl pyrimidine nucleosides were designed and synthesized from d‐ribose as starting material. The synthetic strategy signifies that tosylation followed by in situ cyclization, one‐pot controlled oxidative cleavage and acetylation by Pb(OAc)4, stereoselective nucleobase condensation, inversion of hydroxyl group and uracil group converted to cytosine as the key steps. Synthesized apioarabinofuranosyl pyrimidine nucleosides were tested using breast, colon, and ovarian cancer cell lines. However, only compound 19a, 19b, and 22b have a moderate growth‐suppressive effect against the luminal A breast cancer cell line MCF7. [ABSTRACT FROM AUTHOR] |
| Databáze: |
Complementary Index |
| Externí odkaz: |
|
Plný text